On January 9, 2026, Regency Centers Corporation (NASDAQ: REG) received a neutral rating from Haendel St. Juste at Mizuho, a shift that highlights a cautious yet optimistic outlook within the retail ...

In a notable move for investors, TD Cowen analyst Jeffrey Osborne upgraded SolarEdge Technologies, Inc. (SEDG) to a “Buy” rating on January 9, 2026, with a price target set at $38. This upgrade comes ...

QUALCOMM Incorporated (NASDAQ: QCOM) received a Neutral rating from analyst Vijay Rakesh at Mizuho, presenting investors with a cautious outlook for the semiconductor giant. This rating shift comes as ...

Waste Management, Inc. (WM) received a bullish endorsement from UBS analyst Jon Windham, who issued a Buy rating accompanied by a price target of $260. This represents a notable upside from the ...

Essex Property Trust, Inc. (ESS) received a “Market Perform” rating from John Kim at BMO Capital on January 9, 2026, a ...

Southwest Airlines Co. (LUV) has received an upgrade to “Overweight” from Jamie Baker at JP Morgan as of January 9, 2026, indicating a bullish outlook from one of Wall Street’s leading analysts. With ...

Generac Holdings Inc. (GNRC) was upgraded to an “Outperform” rating by Michael Halloran of Baird, setting a price target of $215. This optimistic outlook comes at a time when the stock is priced at ...

Steel Dynamics, Inc. (ticker: STLD) garnered attention within investment circles as Morgan Stanley analyst Carlos De Alba issued an Equal-Weight rating on the stock, along with a price target of $194.

On January 9, 2026, iHeartMedia, Inc. (IHRT) received a sell rating from Goldman Sachs analyst Stephen Laws, raising questions about the company’s near-term prospects amidst ongoing fluctuations in ...

MoonLake Immunotherapeutics (MLTX) is garnering attention in the investment community following a recent upgrade to a Buy rating from BTIG analyst Julian Harrison. This bullish outlook comes with a ...

Mattel, Inc. (MAT) experienced a notable shift in sentiment last week, as Goldman Sachs analyst Stephen Laszczyk assigned a Neutral rating to the company o. This cautionary stance comes at a time when ...

HealthEquity, Inc. (HQY) has recently been downgraded to a “Sell” rating by David Roman of Goldman Sachs, with a price target slashed to $89 from earlier estimates. This change comes at a time when ...